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Non-invasive brain stimulation (NIBS) techniques can significantly modulate cognitive
functions in healthy subjects and patients with neuropsychiatric disorders. Recently,
they have been applied in patients with mild cognitive impairment (MCI) and subjective
cognitive impairment (SCI) to prevent or delay the development of Alzheimer’s disease
(AD). Here we review this emerging empirical corpus and discuss therapeutic effects
of NIBS on several target functions (e.g., memory for face-name associations and
non-verbal recognition, attention, psychomotor speed, everyday memory). Available
studies have yielded mixed results, possibly due to differences among their tasks,
designs, and samples, let alone the latter’s small sizes. Thus, the impact of NIBS on
cognitive performance in MCI and SCI remains to be determined. To foster progress in
this direction, we outline methodological approaches that could improve the efficacy and
specificity of NIBS in both conditions. Furthermore, we discuss the need for multicenter
studies, accurate diagnosis, and longitudinal approaches combining NIBS with specific
training regimes. These tenets could cement biomedical developments supporting new
treatments for MCI and preventive therapies for AD.
Keywords: mild cognitive impairment, non-invasive brain stimulation, neuroenhancement, transcranial magnetic
stimulation, transcranial direct current stimulation
INTRODUCTION
In the face of an aging society, an urgent need has emerged to prevent and treat dementia, in general,
and Alzheimer’s disease (AD), in particular (Ferri et al., 2006). Despite wide-ranging research
efforts to elucidate the putative pathological mechanisms of dementia, available treatments remain
limited (Alzheimer’s Association, 2012). Promisingly, however, various factors have been shown
to boost the dynamics of relevant neural networks, delaying and even reducing clinical symptoms
(Fregni and Pascual-Leone, 2007). Therefore, interventions that enhance neuroplastic responses
in early disease stages might be particularly useful to attenuate the rate of cognitive decline in AD
patients.
A key model to assess this possibility is afforded by patients with mild cognitive impairment
(MCI). This construct has evolved over the past two decades to denote a cognitive state intermediate
between normal aging and very early dementia (Petersen and Negash, 2008). Patients with
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this condition feature objective memory impairment and other
cognitive deficits, but their dysfunction is not so severe as to
compromise daily activities (Petersen and Negash, 2008). MCI
comprises four clinical subtypes: (i) single-domain amnestic
MCI (aMCI); (ii) multiple-domain aMCI; (iii) single-domain
non-amnestic MCI; and (iv) multiple-domain non-amnestic
MCI (Winblad et al., 2004; Anstey et al., 2008; Albert et al.,
2011). These subtypes differ in etiology and outcome: whereas
both forms of aMCI imply a high chance of progression to AD,
non-amnestic varieties involve considerable risk of conversion
to non-AD dementia (Winblad et al., 2004; Anstey et al., 2008;
Albert et al., 2011).
A second relevant model can be found in individuals featuring
subjective cognitive impairment (SCI). This notion encompasses
people who report everyday concerns about their cognitive
functioning, even in the absence of objectively established
impairments. Given its association with subsequent cognitive
decline, SCI represents a potential prodromal state of AD
occurring even before MCI (Reisberg and Gauthier, 2008).
In sum, aMCI and SCI are likely to anticipate incipient
dementia. Despite the high between-patient variability and
the uncertainty about their causative physiopathological
mechanisms, both conditions offer highly relevant models
to implement interventions aimed to boost cognitive
performance through modulations of neuronal activity and
connectivity. In this sense, non-invasive brain stimulation
(NIBS) techniques have emerged as a potentially useful
alternative. These tools can selectively enhance adaptive
activity patterns, suppress maladaptive patterns, and
influence learning and skill acquisition processes by inducing
synaptic plasticity and network reorganization (Hummel
and Cohen, 2006; Nitsche et al., 2008). In particular,
NIBS can have a direct impact on memory mechanisms
(including working, episodic, and associative memory) in
young adults, elderly adults and patients with neurological
dysfunctions (Manenti et al., 2012; Elder and Taylor,
2014).
Building on these antecedentes, a number of studies have
assessed the impact of NIBS on MCI patients. Here we aim to
critically review such emerging literature. While other reviews
have addressed the impact of NIBS in cognitively impaired
patients (Freitas et al., 2011; Nardone et al., 2014), here we
focus on the key questions and difficulties of setting a treatment
protocol. To this end, first we characterize the main features
of NIBS. Thereupon, we review available studies examining the
impact of NIBS on learning and memory in MCI and SCI.
In particular, we describe and discuss in detail the studies’
protocols and parameters, highlight the advantages of combining
NIBS with cognitive training. Finally, we outline methodological
strategies that could promote major developments in this
promising research area.
NIBS: FEATURES AND MECHANISMS
With NIBS, researchers can transiently influence behavior by
altering neural activity (Miniussi et al., 2013). A considerable
body of evidence has been forged through the two most
commonly used techniques in humans: repetitive transcranial
magnetic stimulation (rTMS) and transcranial direct current
stimulation (tDCS). Although they differ in several aspects
(Table 1), both tools can induce long-term after effects on
cortical excitability and neuronal plasticity. Typically, this
brings about facilitatory or inhibitory effects (Nitsche and
Paulus, 2000), broadly mirroring the workings of long-term
potentiation (LTP) and long-term depression (LTD; Dayan
et al., 2013). Since such effects can considerably outlast the
actual stimulation period, NIBS techniques open valuable
avenues for rehabilitation, especially when stimulation protocols
are combined with adequate training-based interventions
(Zimerman et al., 2013).
TABLE 1 | Summary of the main features of non-invasive brain stimulation (NIBS) techniques.
TMS tDCS
Excitatory High frequency >5 Hz Anodal stimulation
Inhibitory Low frequency ∼1 Hz Cathodal stimulation
Mechanism of action Neuronal depolarization Membrane modulation
Physiological substrate NMDA receptor Voltage-dependent sodium and calcium channels;
NMDA receptor
Focality of stimulation More focal Less focal
Design of sham-controlled double-blind studies More difficult Less difficult
Synchronous application with specific training More difficult Less difficult
Discomfort or pain Mild following sustained application Mild at the beginning
Adverse effects Rare, if applied in accordance with safety guidelines Rare, if applied in accordance with safety guidelines.
Sensory discomfort, occasional headaches, no
seizures described
Time resolution Excellent: milliseconds Poor
Cost Higher Lower
Simultaneous combination with EEG Possible, but with several TMS-related artifacts Possible. However, brain activity cannot be synchronously
recorded from the same channels used for stimulation
Simultaneous combination with fMRI Possible Possible, but with electrode artifacts and the remote risk of
sudden electrode heating
Portability Not portable Portable
Modified from Zimerman and Hummel (2010).
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TMS has been recently approved in some countries to treat
depression and other disorders, subject to approval by local
ethical review boards (Rossi et al., 2009). These reservations
largely follow from the suboptimal understanding of the
putative mechanisms underlying NIBS-related effects. However,
a number of contributing factors have been recently identified.
A critical one concerns modulation of neurotransmitter levels
(Ridding and Ziemann, 2010). Transcranial stimulation may
alter the dynamics of excitatory/inhibitory neurotransmitter
systems (e.g., GABA and glutamate) affecting the regulation
of cortical neuronal activity. For example, rTMS effects
decrease if the subjects consume a drug that interferes with
NMDA receptors (Reis et al., 2006). Likewise, post-tDCS
effects can be blocked by an NMDA-antagonist, whereas a
partial NMDA-agonist (d-cycloserine) can selectively extend
the duration of motor cortical excitability induced by anodal
tDCS (Nitsche et al., 2004). Moreover, MR spectroscopy
research (Stagg et al., 2009) shows that anodal tDCS decreases
GABAergic transmission, while cathodal tDCS yields similar
effects on glutamate concentrations over the motor cortex
(MC).
NIBS may also exert long-lasting plastic changes through
gene induction. Research based on rTMS protocols (Fritsch
et al., 2010) has shown significant enhancements of brain-derived
neurotrophic factor (BDNF)mRNA in the hippocampal, parietal,
and piriform cortices. For instance, LTP-like effects in adult
mice are abolished for specimens with deletion of the BDNF
gene, suggesting that this factor could be a critical mediator of
direct stimulation effects (Fritsch et al., 2010). Importantly, as a
member of the neurotrophin family, BDNF plays an important
role in synaptogenesis and synaptic mechanisms related to
learning and memory processes.
Additionally, TMS has been successfully used in AD
and MCI to track and modulate abnormal mechanisms,
including glutamatergic dysfunctions, disruption of synaptic
plasticity, and inhibition of LTP (Nardone et al., 2014). For
example, TMS research consistently shows that such patients
feature a decreased resting motor threshold, which has been
interpreted as the electrophysiological correlate of cortical
glutamatergic dysfunctions and as a marker of reduced cortical
hyperexcitability in AD (Di Lazzaro et al., 2003, 2004; Inghilleri
et al., 2006; Trebbastoni et al., 2016). Furthermore, rTMS
reduces facilitation of the motor-evoked potential (MEP) in
aMCI patients (Trebbastoni et al., 2016), revealing an initial
impairment of the mechanisms that underlie glutamate-induced
synaptic potentiation (Trebbastoni et al., 2016). On the other
hand, a TMS-MRI study indicates that hyperexcitability of the
sensorimotor cortex might represent a protective mechanism
counteracting the prominent loss of cortical volume in AD
and MCI. However, this supposed protective mechanism was
found neither on the precuneus or cuneus of AD patients,
nor in an MCI group (Niskanen et al., 2011). Furthermore,
an assessment of navigated TMS-evoked EEG responses in AD
patients showed prominent changes in functional connectivity
and reactivity (Julkunen et al., 2008, 2011). In particular,
TMS-evoked responses at 30–50 ms decreased significantly in
AD over widespread brain regions, suggesting dysfunctions of
a large-scale sensorimotor network. Compatibly, a TMS-EEG
co-registration study in AD patients offered direct evidence
of MC hyperexcitability, extending to the whole sensorimotor
system (Ferreri et al., 2016). Although speculative, these changes
could be interpreted as a compensatory mechanism allowing for
the preservation of sensorimotor programming and execution
over a long period, regardless of the disease’s progression.
Additional evidence on cortical plasticity in relevant patient
samples comes from paired associative stimulation (PAS) and
cortical responses to rTMS. Null PAS effects in MCI patients
have been reported by Lahr et al. (2016). However, this
result should be considered with caution, since the study
mixed patients with single- and multiple-domain aMCI which
may have clouded effects on a specific subsample. Indeed,
previous evidence from Nardone et al. (2012) demonstrated
that short-latency afferent inhibition is significantly reduced
in patients with multiple-domain amnestic MCI relative to
controls, but not in patients with single-domain amnestic MCI
or with non-amnestic MCI. Taken together, this incipient
evidence suggests that NIBS can directly impinge on the
pathological mechanisms underlying some forms of AD and
MCI.
Finally, note that the effects of rTMS and tDCS are not
restricted to the stimulation site. Depending on stimulation
parameters, they can induce changes at distant points through
effective modulations of remote, interconnected networks
(Plewnia et al., 2003; Hummel and Cohen, 2006). This particular
property of NIBS techniques has been assessed in proof-of-
principle studies aimed to enhance and decrease excitability
of critical brain regions involved in the recovery process (for
details see Hummel and Cohen, 2006; Nowak et al., 2010; Schulz
et al., 2013). All these tenets illuminate the evidence gathered
so far in NIBS studies on MCI patients, which we review
below.
DOES NIBS IMPROVE LEARNING AND
FORMATION OF NOVEL MEMORIES IN
MCI?
Growing evidence indicates that NIBS techniques can
significantly modulate various cognitive processes in both
elderly neurotypicals and patients with AD. While the impact
of NIBS on the latter population has been widely discussed
(Hsu et al., 2015), much less attention has been paid to NIBS
research on MCI and SCI. Below we offer a joint assessment of
this empirical corpus, discussing available results in terms of
stimulated brain regions. We deal with TMS studies first, and
then consider those employing tDCS (for full details of each
study see Table 2).
TMS Studies with MCI Patients
Prefrontal Cortex
In a study with SCI patients, Solé-Padullés et al. (2006)
reported improvements of face-name associative memory
following up-regulation of the bilateral prefrontal cortex (PFC)
through high-frequency (5 Hz) rTMS. Specifically, the behavioral
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enhancement positively correlated with the recruitment of
the right PFC and posterior bilateral cortices, as shown
by fMRI. In another study, Turriziani et al. (2012) found
improvements of non-verbal recognition memory in MCI
patients after low-frequency (1 Hz) stimulation and subsequent
down-regulation of the right but not the left dorsolateral
prefrontal cortex (DLPFC). Morever, a double-blind randomized
sham-controlled study using 10-Hz rTMS in MCI patients
(Drumond Marra et al., 2015) showed that up-regulation of the
DLPFC led to improvements in everyday memory. Interestingly,
this enhancement remained for at least a month. However,
stimulation of prefrontal structures has also yielded null results.
In particular, a blind study with a crossover design (Sedlackova
et al., 2008) failed to induce positive or negative behavioral effects
following either low- or high-frequency rTMSof the DLPFC in
seven patients with vascular MCI.
Parietal Cortex
In a single-case study with an aMCI patient, Cotelli et al.
(2012) assessed whether up-regulation of the left parietal
cortex could lead to long-term improvements in face-name
associations. The 10-day protocol consisted in daily 25-min-
long stimulation sessions with high-frequency (20 Hz) rTMS.
Behavioral enhancements suggested a putative role of the target
region in associative memory.
Inferior Frontal Gyrus and Superior Temporal Gyrus
Two related studies Eliasova et al. (2014) and Anderkova et al.
(2015) found that rTMS significantly improved Stroop-task
performance in aMCI and AD patients. The stimulation
protocol comprised three randomized 22-min-long sessions,
during which 10-Hz rTMS was applied over the IFG, the
right superior temporal gyrus (STG), and the vertex (VTX,
a control stimulation site). As compared to the VTX, both
IFG and STG simulation improved the patients’ behavioral
outcome. In particular, through a combination of rTMS and
MRI, Anderkova et al. (2015) found that MCI/AD subjects had
significant atrophy in the inferior temporal and fusiform gyri,
putamen and cerebellum relative to healthy controls. Moreover,
the level of atrophy correlated with the change in Stroop-task
performance after rTMS of the STG.
Interim Summary
Taken together, these studies indicate that rTMS can have
significant effects on cognitive functions in patients with SCI
and MCI. Specifically, this form of stimulation appears to
enhance face-name association memory, non-verbal recognition
memory, attention, psychomotor speed, and everyday memory.
However, inconsistencies among comparable studies and null
results in some of them cast doubts on the robustness of this
technique to restore cognitive function in MCI. A number
of caveats can be identified. First, rTMS might not directly
stimulate deep brain areas critically compromised in MCI
and AD (e.g., the hippocampus). Second, discrepancies in
stimulation parameters (frequency, intensity, duration, number
of sessions, stimulation site) and experimental design across
studies make it difficult to determine which configuration could
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systematically yield effective results. Finally, there is only one
double-blind randomized sham-controlled rTMS study with
MCI patients. Thus, further work andmore randomized placebo-
controlled studies are needed to establish the optimal stimulation
parameters for potential treatments in this population. Critically,
a more through characterization is needed of how results are
influenced by multiple interrelated factors, such as the patients’
clinical profile, specific target areas, stimulation frequency,
number of treatment sessions, sessionduration and specific
cognitive domains tapped through selected behavioral tasks.
tDCS Studies with MCI Patients
To date, only two studies have explored the potential
neurocognitive benefits of anodal tDCS in MCI patients.
The target regions in them were the IFG and the PFC.
Inferior Frontal Gyrus
Meinzer et al. (2015) performed a double-blind, crossover,
sham-controlled stimulation study with simultaneous
task-related and resting-state fMRI recordings. An
MRI-compatible stimulator was used to administer a constant
direct current (1 mA, for 20 min) over the IFG. During sham
stimulation, MCI patients produced fewer correct responses
than healthy controls in a semantic fluency task. Interestingly,
the degree of correct responses was associated with hyperactivity
in bilateral prefrontal regions. Anodal tDCS significantly
improved performance in MCI patients to healthy-control levels.
Furthermore, such stimulation reduced task-related prefrontal
hyperactivity and normalized altered network configurations at
during resting state. This study provides evidence that anodal
tDCS could ameliorate cognitive dysfunction in MCI patients
and temporarily reverse abnormalities in relevant brain activity.
Prefrontal Cortex
A recent study assessing MCI patients with Parkinson’s disease
(PD; Manenti et al., 2016) evaluated the impact of up-regulating
the right or left DLPFC via anodal tDCS combined with physical
therapies. For 2 weeks, patients underwent daily administration
of 2-mA stimulation during 25 min. Scores on the PD Cognitive
Rating Scale and a verbal fluency test increased only in the real
tDCS group (compared with the sham group). Notably, the effect
remained stable for up to 3 months after the intervention.
Interim Discussion
These extremely preliminary results suggest that anodal tDCS
can ameliorate cognitive dysfunction in different subtypes of
MCI. In particular, long-term results obtained by combining
stimulation with physical training open interesting avenues for
further research.
CHALLENGES AND FUTURE DIRECTIONS
So far, NIBS studies seeking to improve cognitive function in
MCI/SCI patients have yielded inconclusive findings. Although
some studies showed favorable results, statistically significant
differences in an experimental setting do not necessarily imply
clinical applicability. Consequently, the evidence gathered so far,
though promising, must be considered extremely preliminary.
No definite answer can yet be provided for the ultimate question
underlying the field: can NIBS-induced cognitive improvements
persist beyond treatment and translate into daily-life benefits?
The methodological considerations listed below emerge as
critical milestones to properly address this issue.
Stimulation Parameters
A number of methodological considerations and caveats must be
addressed before claiming that a genuine, reliable and replicable
effect has been found. TMS stimulation protocols involve
several parameters, such as stimulation frequency, intensity, coil
shape, pulse and stimulation site. While neuroimaging tools
have improved selection of target areas for stimulation, the
latter are typically anatomically ill-defined and hugely variable
among individual brains. This heterogeneity is reduced by using
neuronavigation procedures and factoring individual anatomy
into the protocol, thus maximizing the chances that one specific
target node is being systematically stimulated within a critical
network (Danner et al., 2008). Regarding stimulation frequency
and intensity, a general finding is that TMS increases neuronal
excitability above a 5-Hz frequency, whereas it yields the opposite
effect below 1 Hz (Hallett, 2000; Sparing et al., 2001; Knoch et al.,
2006). Stimulation intensity in TMS protocols is usually defined
as a percentage of a subject’s individual motor threshold, namely,
the minimal stimulation intensity that induces a reliable motor
evoked potential of minimal amplitude in the targeted muscle
(Rossini et al., 2015). This measure is useful to determine the
intensity needed to comparably stimulate primary motor regions
across subjects. However, the relevance of this parameter remains
unknown for the stimulation of other cortical regions. Future
research should examine the possibility of designing subject- and
area-specific simulation protocols (Klooster et al., 2016), together
with region-specific stimulation-tuning.
In the case of tDCS, key parameters include electrode
patch positioning, inter-electrode distance, stimulation duration,
and stimulation intensity (Klooster et al., 2016). With this
technique, anodal and cathodal currents increase and inhibit
neural-network activity, respectively. In this sense, one important
difference with TMS is that tDCS allows stimulating and
inhibiting different target regions at the same time (Ferrucci
et al., 2009; Lindenberg et al., 2010; Mahmoudi et al., 2011),
which increases the range ofmethodological decisions on the part
of researchers. Another factor known to modulate tDCS results
is age. Indeed, montages inducing effects in young adults do not
necessary yield the same results in older adults (Zimerman et al.,
2013). This highlights the importance of considering information
about age-associated brain reorganization when aiming to induce
durable neuroplastic effects in aging subjects (Perceval et al.,
2016), including MCI patients.
Behavioral Effects of Stimulation in
Combination with Cognitive Training
Typically, neuro-rehabilitation protocols aim to stimulate the
whole spatially-distributed network subserving a target cognitive
function. To guarantee that the right mechanisms are being
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stimulated, brain enhancement must be combined with training
of key relevant functions. Theoretically, targeting a dysfunctional
neural circuit while it is actively engaged by a behavioral task
should bring about better therapeutic effects than mere resting-
state stimulation of the same area (Miniussi et al., 2013).
Given that both cognitive training and NIBS can enhance
adaptive plastic mechanisms, their combination could produce
synergistic positive effects on behavior (Ditye et al., 2012). This
approach offers a chance to stimulate very precise neurocognitive
mechanisms, implement experimental designs with strict control
of stimulus- and task-related factors and increase protocol
viability through short-term longitudinal or pre/post models.
To date, this combined approach has been used in only
one study (Park et al., 2014). After 10 daily sessions of
tDCS with cognitive training, healthy elderly subjects increased
working memory skills for up to 28 days. However, as this
study lacked a control group without training, no further
conclusions can be drawn regarding the potential benefits
of combined NIBS-training interventions. Also relevant is
the study protocol proposed by Cheng et al. (2015), aimed
to improve working memory in aMCI patients. The design
consists of a 4-week, double-blind, randomized controlled trial
involving anodal tDCS or sham intervention combined with
a working memory (n-back) paradigm or a control cognitive
training condition. They hypothesize that this joint approach
could significantly improve cognitive performance relative to
isolated NIBS or n-back training. Furthermore, one of the
studies reviewed above Manenti et al. (2016) reported cognitive
enhancements in PD patients by combining tDCS with physical
exercise cognitive enhancements. Taken together, this incipient
evidence suggests that significant and long-lasting cognitive
improvements could be induced through a combination of NIBS
and specific cognitive training in MCI/SCI patients. Future
research in the field should test this hypothesis by comparing
the impact of joint and single-method interventions in both
populations.
The Critical Questions
Where to Stimulate?
Most of the reviewed studies targeted the DLPFC, a region
implicated in workingmemory, everydaymemory and automatic
processing of learned tasks. These functions, indeed, were
enhanced by NIBS in MCI patients and healthy subjects
(Turriziani et al., 2012; Iuculano and Cohen Kadosh, 2013;
Drumond Marra et al., 2015). Another region targeted within
the frontal lobe has been the IFG. Stimulation over this
structure significantly improved word retrieval and decreased
hyperactivity in the bilateral PFC, the right middle temporal
gyrus, the left basal ganglia, and the thalamus (Meinzer et al.,
2015). Furthermore, rTMS over the STG has been observed to
improve processing speed (Anderkova et al., 2015). Encouraging
results have also been obtained through stimulation of the
inferior parietal lobe, which enhanced associative and long-term
memory in MCI patients (Cotelli et al., 2012). In this sense, note
that other portions of the parietal cortex are known to increase
blood oxygen level-dependent signals during working memory
storage (Linden et al., 2003; Xu and Chun, 2006). The relevance
of parietal structures as promising target areas for NIBS in MCI
samples is highlighted by its role in cognitive impairments during
early stage AD (Reiman et al., 2012; Weintraub et al., 2012).
In sum, available evidence highlights the relevance of specific
prefrontal, frontal, temporal, and parietal areas as key targets to
develop more robust stimulation protocols in MCI. The main
findings emerging from their stimulation in MCI patients are
summarized in Figure 1.
How to Stimulate?
In general, rTMS protocols follow an offline approach, testing
hypothesized cognitive changes roughly 30–60 min after
stimulation (Ziemann et al., 2008). The use of patterned
rTMS protocols, like theta burst stimulation, allows delivering
600 pulses with sub-threshold intensity in less than a minute.
This induces longer-lasting effects in a shorter delivery time
(Suppa et al., 2016). The impact of theta burst stimulation
has been examined in several psychiatric conditions, like
schizophrenia and obsessive-compulsive disorder (Suppa et al.,
2016). However, studies in patients withmemory impairment are
still lacking.
On the other hand, tDCS is a smaller, portable tool which
allows designingmore ecological paradigms and obtaining online
measurements. Thus, tDCS can be used to stimulate a particular
neural network during behavioral intervention. Thanks to new
developments, tDCS protocols can now employ more than two
electrodes, enabling multifocal stimulation of brain networks to
increase neurofunctional precision (Alam et al., 2016).
For increased effectiveness, NIBS can be applied in multi-
session designs. Cognitive improvement in MCI patients is
increased over time by repetitive, daily rTMS sessions (Cotelli
et al., 2012; Drumond Marra et al., 2015). An alternative
approach could rely on the use of spaced stimulation patterns,
with multiple daily sessions. This might potentially lead to
prolonged after effects via late-phase LTP/LTD-like neuroplastic
mechanisms (Goldsworthy et al., 2015). Regarding tDCS,
Manenti et al. (2016) worked with PD patients and found
cognitive improvements lasting at least 3 months, after 10 daily
sessions (Manenti et al., 2016). The only study employing tDCS
in MCI patients employed a single-session protocol (Meinzer
et al., 2015), so that no evidence is available on whether multiple-
session tDCS protocols can induce long-term beneficial effects in
this population.
Another important challenge lies in combining NIBS with
daily life activities. This includes home-based training focused
on specific cognitive skills. Self-delivered NIBS by the patient
in a household environment, ideally according to a patient-
specific stimulation protocol, may be a crucial step to hone the
applicability of tDCS as a therapeutic tool (Klooster et al., 2016).
To be effective, home-based portable devices should incorporate
features which guarantee that stimulation is applied over the
right brain regions, such as patient-specific cap-positioning tDCS
electrodes. This may result in more efficient and less expensive
cognitive intervention. In consequence, future research should
develop new paradigms and technologies specific to each patient
and relevant target areas.
Frontiers in Aging Neuroscience | www.frontiersin.org 7 February 2017 | Volume 9 | Article 16
Birba et al. Non-Invasive Brain Stimulation in MCI
FIGURE 1 | Visual summary of main results from non-invasive brain stimulation (NIBS) studies with mild cognitive impairment (MCI) patients. Lateral
view of the left hemisphere. Target areas stimulated in the reviewed studies are highlighted in different colors. DLPFC, dorsolateral prefrontal cortex; IFG, inferior
frontal gyrus; STG, superior temporal gyrus; IPL, inferior parietal lobule; atDCS, anodal transcranial direct current stimulation; rTMS, repetitive transcranial magnetic
stimulation; ↑ behavioral improvement; ↓ behavioral decrement; UR, up-regulation; DR, down-regulation.
Whom to Stimulate?
The use of NIBS to enhance memory in the elderly represents
a promising avenue for both basic and translational research.
However, the effects of NIBS likely depend on inter-individual
differences in the degree of age-related cognitive impairment
and brain reorganization (Craik, 1994; Mungas et al., 2010;
Reuter-Lorenz and Park, 2014), under the influence of
various genetic and lifestyle factors (Bishop et al., 2010;
Grady, 2012). Moreover, different subtypes of MCI may
respond in different ways to the same stimulation protocols.
This calls for further research on the multiple subject-
related variables that can modulate results within and across
studies.
Correct diagnosis of MCI subtypes proves critical to discern
stimulation effects. Approximately 50% of patients with aMCI
convert to AD within 5 years (Gauthier et al., 2006). Also,
different genetic influences impact on the development of AD.
For instance, the presence of one or two ε4 alleles in the
apolipoprotein E (APOE) gene confers risk of AD. An individual
who meets the clinical, cognitive and etiologic criteria for MCI,
and is also APOE ε4 positive, is more likely to progress to
AD dementia within a few years than an individual without
this genetic trait (Winblad et al., 2004; Anstey et al., 2008;
Albert et al., 2011). Conversely, other familial versions will
progress to AD with a 100% of probability (e.g., presenilin
1, PS1). Moreover, despite well-established risk genes (e.g.,
APOE, SORL1) or causative genes (e.g., APP, PSEN1, PSEN2)
of AD, more than 20 loci have been associated with disease
risk (Karch et al., 2014). In this sense, the epigenetic approach
to clinical phenotypes offers a promissory agenda (Bennett
et al., 2015). The need thus arises for more research on the
interaction between NIBS and previous genetic risk in the
MCI-AD spectrum.
On the other hand, fewer prognostic data are available
about patients with non-memory-related impairments, who
may develop non-AD dementia (Winblad et al., 2004; Anstey
et al., 2008; Albert et al., 2011). Three out of the nine articles
reviewed in ‘‘Does NIBS Improve Learning and Formation
of Novel Memories in MCI?’’ Section targeted aMCI patients
(Cotelli et al., 2012; Eliasova et al., 2014; Anderkova et al.,
2015), one focused on vascular MCI (Sedlackova et al., 2008),
and another one assessed MCI linked to PD (Manenti et al.,
2016). The rest did not specify the MCI subtype. This
distinction is crucial to assess the efficacy and extent of the
stimulation protocol. For example, no effects were observed
in vascular MCI when stimulating the DLPFC with rTMS
(Sedlackova et al., 2008). It seems that each subtype of MCI
could respond different to stimulation, although it is not
clear which ones would profit the most from intervention.
In consequence, it is necessary to stratify MCI subtypes to
recognize condition-specific stimulation effects and develop
more fine-grained protocols for each patient, according to his or
her diagnosis.
Finally, given that aMCI patients may be at increased
risk of developing AD, future interventions might focus on
familial-MCI patients with high probability to progress into
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AD. Early-onset AD patients present MCI, rapidly followed
by severe deficits in cortical functions (aphasia, apraxia,
and agnosia), whereas late-onset AD patients show a slower
overall decline and pronounced memory deficits, particularly
in the semantic domain (Joubert et al., 2016). Since the
progression of early-onset AD is faster than in late-onset
AD, the latter variety may profit more from NIBS as a tool
to attenuate the rate of cognitive decline. The identification
of causative genetic mutations leading to early-onset AD
(APP, PSEN1, PSEN2) and susceptibility markers associated
with later disease onset (e.g., APOE ε4 carriers) is crucial
to determine specific patterns of cognitive impairment in
younger patients with a family history of AD or other
neurodegenerative diseases (Rocchi et al., 2003; Winblad et al.,
2004; Albert et al., 2011), and to better screen candidates for
different stimulation protocols targeting specific neurofunctional
mechanisms.
A Call for Multicenter Studies
A thorough understanding of potential neurocognitive changes
induced by NIBS requires protocols to be complemented
with other functional techniques, like electroencephalography
(EEG), magnetoelectroencephalography (MEG), positron-
emission tomography (PET), fMRI, and magnetic resonance
spectroscopy (MRS). Therefore, the direct comparison of
neuro-anatomical changes before and after stimulation could
shed light on the potentially specific effects of NIBS. Also,
the establishment of NIBS techniques as therapeutic tools
for MCI requires systematic assessment of multiple subject
variables (e.g., cortical thinning, white matter volume and
integrity, functional and structural connectivity, genetic
variants, learning capacity, age at disease onset and cognitive
reserve). In order to gain multidimensional insights into the
impact of NIBS in MCI, above and beyond between-subject
variability, longer multicenter studies are urgently needed. By
revealing common patterns despite differences in diagnosis,
sociodemographic factors, neurobiological features, brain
recording parameters, measurements, and analyses, such
joint protocols will help identify the most consistent changes
induced by NIBS, while revealing the most effective stimulation
parameters.
In this context, the implementation of normative databases
based on neuroscientific techniques might help to recognize
abnormal patterns, detect the disease at early stages, and define
treatment protocol strategies (Gordon and Konopka, 2005).
Available EEG neuromarkers of MCI and AD are critical to such
ends (Ibanez and Parra, 2014). Quantitative EEG (qEEG) shows
that AD and MCI are characterized by increased theta power,
decreased alpha and beta power and decreased coherence in the
alpha and theta band in posterior regions (Jelic et al., 2000).
These abnormalities are thought to be associated with functional
disconnections among cortical areas, loss of cortical neurons,
axonal degeneration, and cholinergic deficits. Furthermore,
EEG/MEG techniques have been useful to characterize AD
and to detect changes in preclinical familial AD and MCI
(Jackson and Snyder, 2008; Stam, 2010; Pietto et al., 2016). For
example, source EEG functional network disruption in AD and
MCI is associated with cognitive decline (Gianotti et al., 2007;
Kurimoto et al., 2008; Ishii et al., 2010; Hsiao et al., 2013)
and APOE genotype (Canuet et al., 2012). Moreover, relative
to normative samples, subjects with SCI present elevated alpha
power and increased number of spatiotemporal wave events
(Alexander et al., 2006). Furthermore, event-related potential
(ERP) measures have shown utility in predicting the conversion
to dementia among elderly individuals at risk for AD (Gironell
et al., 2005). Beyond its to diagnose functional impairment,
EEG is also useful to set stimulation parameters and assess
the effect of NIBS in patients (Kropotov, 2016). Combining
NIBS with EEG would help to identify stimulus intensity,
frequency of the stimulation, location, and duration needed to
normalize EEG activity (Jin et al., 2012). This is critical since
most rTMS protocols use the same parameters for all patients.
With this approach, a customized treatment would be available
for each individual based on analysis of resting EEG. In this
sense, Marceglia et al. (2016) applied tDCS to change cortical
activity as represented by qEEG. Despite working on a small
sample, the authors found that the abnormal pattern of EEG
activity in AD during memory processing is partially reversed by
anodal transcranial direct current stimulation (atDCS) and this
reversion correlated with an improvement in word recognition,
suggesting that such benefits are supported by the modulation
of neuronal cortical activity. In conclusion, normative databases
should be systematically considered as a reference to establish the
efficacy of individualized stimulation protocols.
CONCLUSIONS
The present review aimed to summarize research on the
effects of NIBS in MCI and to outline the approaches that
may improve the efficacy of stimulation protocols. Despite
major advances over the past few decades, extant MCI/AD
treatments are not completely effective. Although NIBS have
not yet been massively applied in SCI/MCI patients, available
results hold considerable promise. First, TMS and tDCS are
well-suited to explore brain plasticity across the lifespan
(Heise et al., 2014). Second, they provide valuable physiologic
biomarkers of the state of cortical reactivity, brain network
connectivity, dynamics, and mechanisms of brain plasticity.
Third, NIBS techniques avoid systemic side-effects and allow
for temporally and spatially precise neural interventions that
escape the possibilities of pharmacological or complementary
therapies. Moreover, discrepancies among available studies
may be largely due to differences among tasks, designs, and
samples, as opposed to limitations inherent to NIBS. However,
many issues remain to be solved and large longitudinal
studies are needed to more stringently assess the robustness
of available positive results. Furthermore, even if NIBS
techniques proved irrelevant for clinical purposes, they could
remain highly useful for experimental research. While no
definitive conclusions on the efficacy and specificity of NIBS
can be advanced at this stage, our review delineates the
major challenges to be faced in future studies. In this
sense, pre-post neuroimaging designs could reveal putative
mechanisms underlying NIBS effects. Also, concurrent use of
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NIBS techniques with specific tasks targeting impaired domains
in individual patients could potentially enhance LTP-like after-
effects. In particular, applying NIBS over a dysfunctional neural
network while the latter is engaged by a particular behavioral
activity could significantly enhance learning- and memory-
related effects. Furthermore, the application of NIBS across
multiple sessions could render such effects longer lasting. All
these considerations should be accompanied by very precise
diagnosis of each patient’s MCI subtype, so that subject-specific
protocols can be designed and assessed with the implementation
of normative databases. Moreover, further studies are required
to identify the optimal stimulation parameters yielding robust
outcomes for different MCI subtypes as well as early- and
late-onset AD. Finally, we emphasize the need to conduct longer
longitudinal studies to establish the duration of NIBS-induced
benefits. By contemplating these issues, future NIBS studies
could shed unprecedented light on functional restoration options
for MCI patients, paving the way for new treatments aimed
to delay (or event prevent) the development of AD and other
dementias.
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